Cost–Benefit Management of Insulin Resistance: Combination of Phentermine and a Flexible Weight Loss Strategy in the Era of GLP-1 Agonists. Visible Benefits Shown After Six Months of Treatment

Metabolism 2026

View at publisher

Authors: César Ochoa, Georgina Roano Iglesias, María Magdalena Valencia Gutiérrez

DOI: 10.1016/j.metabol.2026.156543

Cited by: 0

Fields of Study & Subjects

Diabetes Treatment and Management Pharmacology and Obesity Treatment Diabetes Cardiovascular Risks and Lipoproteins